Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?

Kidney Int. 2011 Apr;79(8):922. doi: 10.1038/ki.2011.5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Cyclophosphamide / administration & dosage*
  • Drug Therapy, Combination
  • Fibrinolysis / drug effects
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • IgA Vasculitis / blood
  • IgA Vasculitis / drug therapy*
  • Nephritis / blood
  • Nephritis / drug therapy*
  • Steroids / administration & dosage
  • Urokinase-Type Plasminogen Activator / administration & dosage

Substances

  • Fibrinolytic Agents
  • Steroids
  • Cyclophosphamide
  • Urokinase-Type Plasminogen Activator